Abstract Cannabinoid receptor 1 (CB1) is a promising therapeutic target for a variety of disorders. Distinct efficacy profiles showed different therapeutic effects on CB1 dependent on three classes of ligands: agonists, antagonists, and inverse agonists. To discriminate the distinct efficacy profiles of the ligands, we carried out molecular dynamics (MD) simulations to identify the dynamic behaviors of inactive and active conformations of CB1 structures with the ligands. In addition, the molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) method was applied to analyze the binding free energy decompositions of the CB1-ligand complexes. With these two methods, we found the possibility that the three classes of ligands can be discrimi...
G protein-coupled receptors, also known as GPCRs, are a kind of protein receptors that transfer sign...
The discovery of natural drug metabolites is a leading contributor to fulfilling the sustainable dev...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor that is implicated in a var...
The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor that is implicated in a var...
The binding of a series of small organic molecules, acting as agonists of the cannabinoid receptor C...
Cannabinoid receptors (CB1 and CB2) are signalling proteins which belong to the largest family of tr...
CB1, a member of the G protein-coupled receptor class, is the putative protein target of THC, the ps...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
Abstract The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor (GPCR) that can ex...
The interaction of different ligands with various components of the cannabinergic system was studied...
The type I cannabinoid G protein-coupled receptor (CB1, GPCR) is an intensely investigated pharmacol...
The interaction of different ligands with various components of the cannabinergic system was studied...
The interaction of different ligands with various components of the cannabinergic system was studied...
The cannabinoid CB1 and CB2 receptors belong to the super family of G protein-coupled receptors. A...
G protein-coupled receptors, also known as GPCRs, are a kind of protein receptors that transfer sign...
The discovery of natural drug metabolites is a leading contributor to fulfilling the sustainable dev...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...
The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor that is implicated in a var...
The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor that is implicated in a var...
The binding of a series of small organic molecules, acting as agonists of the cannabinoid receptor C...
Cannabinoid receptors (CB1 and CB2) are signalling proteins which belong to the largest family of tr...
CB1, a member of the G protein-coupled receptor class, is the putative protein target of THC, the ps...
The endocannabinoid system has been historically targeted for medicinal purposes through the use of ...
Abstract The cannabinoid receptor 1 (CB1) is a class A G-protein coupled receptor (GPCR) that can ex...
The interaction of different ligands with various components of the cannabinergic system was studied...
The type I cannabinoid G protein-coupled receptor (CB1, GPCR) is an intensely investigated pharmacol...
The interaction of different ligands with various components of the cannabinergic system was studied...
The interaction of different ligands with various components of the cannabinergic system was studied...
The cannabinoid CB1 and CB2 receptors belong to the super family of G protein-coupled receptors. A...
G protein-coupled receptors, also known as GPCRs, are a kind of protein receptors that transfer sign...
The discovery of natural drug metabolites is a leading contributor to fulfilling the sustainable dev...
Graduate students: AyoOluwa Aderibigbe, Department of BioMolecular Sciences, Division of Medicinal C...